TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial. Issue 2 (December 2015) - Nemunaitis, John; Papai, Zsolt; Léna, Hervé; Losonczy, Gyorgy; Forget, Frederic; Chouaid, Christos; Szczesna, Alexandra; Gervais, Radj; Ottensmeier, Christian; Beck, Joseph; Kazarnowicz, Andrzej; Westeel, Virginie; et al.